We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Alkermes, Elan in $960 million merger.
- Authors
Sinha, Gunjan
- Abstract
The article focuses on the merger of Alkermes drug delivery specialist with Elan Technologies (EDT). It mentions that Elan will be given 500 million U.S. dollars in cash and 460 million U.S. dollars worth of stake in the Alkermes company. It also notes that the merger will allow Alkermes to offer slow-release system for biologic drugs and small molecules drugs while Elan will be focusing on the development of drugs for treatment of neurological disorders.
- Subjects
MERGERS &; acquisitions; ALKERMES Inc.; ELAN Technologies Inc.; PHARMACEUTICAL industry; BIOTECHNOLOGY
- Publication
Nature Biotechnology, 2011, Vol 29, Issue 7, p559
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0711-559b